Tramadol Hydrochloride
Product Images NDC 68071-2410

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-2410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2410 6)

Pdp (68071 2410 6)
This is a description of Tramadol Hydrochloride 100mg Extended-Release tablets. The tablets are circular, white to off-white, and are imprinted with "X" on one side and "L010" on the other side. These tablets are packaged as 60 tablets in a bottle (lot #00000) with an expiration date of 00-00. The manufacturer is NuCare Pharmaceuticals, and the product is only available with a prescription. The tablets contain Tramadol Hydrochloride USP 100mg, which is a pain reliever. Please contact your doctor for medical advice and do not let children access this medication. Store this medication at a controlled temperature of 68-77°F.*
FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)
This is a graph showing the concentration of Tramadol in ng/mL over time in hours. Two types of Tramadol Hydrochloride medications are compared: Tramadol Hydrochloride Extended-Release Tablets (200 mg, once per day) and Tramadol Hydrochloride Tablets (50 mg, every six hours). The concentration of Tramadol decreases with time for both medication types, and the Extended-Release Tablets have a higher initial concentration.*
FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)
This text represents a set of measurements of M1 concentration over time with different doses of two types of tramadol tablets (extended-release and regular) in milligrams. There is a graph with M1 concentration on the y-axis and time on the x-axis, showing the concentrations decreasing over time for both types of tablets. The units of M1 concentration are not specified.*
FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)
This appears to be a study result for Tramadol Hydrochloride Extended-Release Tablets conducted to evaluate the drug's effectiveness in managing arthritis pain. The chart presents the percentage of patients who achieved various levels of response to the drug, as compared to a placebo. The results are measured using the VAS (Visual Analog Scale) Responder Analysis method. The response threshold represents the percentage improvement from baseline in pain intensity.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.